ProMIS Neurosciences Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ProMIS Neurosciences Inc
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
/ 
Frequently asked questions
To buy ProMIS Neurosciences Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ProMIS Neurosciences Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ProMIS Neurosciences Inc is PMN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ProMIS Neurosciences Inc has its primary listing on NASDAQ (Small cap). You can trade ProMIS Neurosciences Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ProMIS Neurosciences Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ProMIS Neurosciences Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ProMIS Neurosciences Inc.